Mirxes Expands Thailand Business With Hospital Partnership, Home Test Launch

MT Newswires Live01-12

Mirxes (HKG:2629) has formed a partnership in Thailand with N Health, a unit of Bangkok Dusit Medical Services (BKK:BDMS), to introduce its microRNA-based cancer screening tests in the country, according to a Jan. 9 Hong Kong bourse filing.

Shares of the micro ribonucleic acid technology company were down nearly 1% in Monday morning trade.

Under the partnership, Mirxes' cancer screening tests will be rolled out across nearly 60 hospitals in N Health's network, with an initial focus on early detection of gastric and lung cancer.

Separately, the company has launched two Thailand FDA-approved at-home diagnostic test kits, HELICORapid for H. pylori infection and FITRapid for fecal occult blood, the filing showed.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2602562569?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-12 10:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2602562569","market":"us","top_or_hot":-1,"title":"Mirxes Expands Thailand Business With Hospital Partnership, Home Test Launch","media":"MT Newswires Live","content":"<html><body><p> Mirxes (HKG:2629) has formed a partnership in Thailand with N Health, a unit of <a href=\"https://laohu8.com/S/BDULF\">Bangkok Dusit</a> Medical Services (BKK:BDMS), to introduce its microRNA-based cancer screening tests in the country, according to a Jan. 9 Hong Kong bourse filing.</p><p>Shares of the micro ribonucleic acid technology company were down nearly 1% in Monday morning trade.</p><p>Under the partnership, Mirxes' cancer screening tests will be rolled out across nearly 60 hospitals in N Health's network, with an initial focus on early detection of gastric and lung cancer.</p><p>Separately, the company has launched two Thailand FDA-approved at-home diagnostic test kits, HELICORapid for H. pylori infection and FITRapid for fecal occult blood, the filing showed.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mirxes Expands Thailand Business With Hospital Partnership, Home Test Launch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMirxes Expands Thailand Business With Hospital Partnership, Home Test Launch\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-01-12 10:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Mirxes (HKG:2629) has formed a partnership in Thailand with N Health, a unit of <a href=\"https://laohu8.com/S/BDULF\">Bangkok Dusit</a> Medical Services (BKK:BDMS), to introduce its microRNA-based cancer screening tests in the country, according to a Jan. 9 Hong Kong bourse filing.</p><p>Shares of the micro ribonucleic acid technology company were down nearly 1% in Monday morning trade.</p><p>Under the partnership, Mirxes' cancer screening tests will be rolled out across nearly 60 hospitals in N Health's network, with an initial focus on early detection of gastric and lung cancer.</p><p>Separately, the company has launched two Thailand FDA-approved at-home diagnostic test kits, HELICORapid for H. pylori infection and FITRapid for fecal occult blood, the filing showed.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02629","symbol_name":"MIRXES-B","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2602562569","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2602562569","pubTimestamp":1768185929,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Mirxes  has formed a partnership in Thailand with N Health, a unit of Bangkok Dusit Medical Services , to introduce its microRNA-based cancer screening tests in the country, according to a Jan. 9 Hong Kong bourse filing.Shares of the micro ribonucleic acid technology company were down nearly 1% in Monday morning trade.Under the partnership, Mirxes' cancer screening tests will be rolled out across nearly 60 hospitals in N Health's network, with an initial focus on early detection of gastric and lung cancer.Separately, the company has launched two Thailand FDA-approved at-home diagnostic test kits, HELICORapid for H. pylori infection and FITRapid for fecal occult blood, the filing showed.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02629":"MIRXES-B","BK1161":"生物科技","BK4195":"互助储蓄与抵押信贷金融服务","HBCP":"Home Bancorp Inc","BK4211":"区域性银行"},"translate_title":"Mirxes与医院合作扩大泰国业务，推出家庭测试","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02629":1,"HBCP":1.5},"content_text":"Mirxes (HKG:2629) has formed a partnership in Thailand with N Health, a unit of Bangkok Dusit Medical Services (BKK:BDMS), to introduce its microRNA-based cancer screening tests in the country, according to a Jan. 9 Hong Kong bourse filing.Shares of the micro ribonucleic acid technology company were down nearly 1% in Monday morning trade.Under the partnership, Mirxes' cancer screening tests will be rolled out across nearly 60 hospitals in N Health's network, with an initial focus on early detection of gastric and lung cancer.Separately, the company has launched two Thailand FDA-approved at-home diagnostic test kits, HELICORapid for H. pylori infection and FITRapid for fecal occult blood, the filing showed.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2602562569","isCrawlerRequest":true}